Literature DB >> 31850620

A survey of U. S. state insurance commissioners concerning genetic testing and life insurance: Redux at 27.

Dexter R Golinghorst1, Anya E R Prince1.   

Abstract

Nearly three decades ago, scientists set out on one of the largest research endeavors in modern history-mapping the human genome. The research not only sparked new technologies and genetic tests, but also concomitant concerns regarding ethical, legal, and social implications of the technologies. These developments ultimately resulted in an expanded role for genetic counselors to educate consumers about the possible consequences of receiving genetic test results. In particular, many individuals undergoing testing worry that the resulting information could be used by social actors, such as life insurers, in harmful ways. Because life insurance is regulated at the state level, there is significant variability across the United States in laws and enforcement protecting consumers' genetic information. This article reports the results of a survey of U.S. state insurance commissioners regarding regulation of genetic testing and life insurance. The survey builds on a 1992 survey conducted by Jean E. McEwen et al. It returns to current U.S. state insurance commissioners to investigate changes in the climate surrounding genetic information use and risks of misuse within the insurance industry. In their 1992 survey, McEwen et al. found that: (a) genetic testing was not yet perceived to pose a significant problem for insurance rating, (b) life insurers had quite a bit of legal freedom to require and use genetic test results, and (c) insurance commissioners had received few consumers' complaints about the use of genetic information. Twenty-seven years later, our survey finds an increase in regulation protecting genetic information in insurance, but at a pace much slower than that of advances in new DNA technologies. This lag in policy to match technology increases potential risks for consumers. Our study further reveals certain inconsistencies in the letter of state law protecting consumers' genetic information and how state insurance commissioners apply that law. The study also shows that despite empirical evidence in the literature demonstrating consumer fear about genetic discrimination, consumers do not report these concerns to their state insurance commissioner. We suggest genetic counselors are key stakeholders who can help fill current gaps between consumers and the insurance industry.
© 2019 National Society of Genetic Counselors.

Entities:  

Keywords:  discrimination; ethics; genetic discrimination; genetic testing; insurance commissioners; life insurance; policy

Mesh:

Year:  2019        PMID: 31850620      PMCID: PMC7299795          DOI: 10.1002/jgc4.1197

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  15 in total

1.  AIDS Confidentiality Act. P.A. 85-677.

Authors: 
Journal:  Smith-Hurd Ill Annot Statut Ill       Date:  1987-09-21

Review 2.  Global trends on fears and concerns of genetic discrimination: a systematic literature review.

Authors:  Annet Wauters; Ine Van Hoyweghen
Journal:  J Hum Genet       Date:  2016-01-07       Impact factor: 3.172

3.  A survey of state insurance commissioners concerning genetic testing and life insurance.

Authors:  J E McEwen; K McCarty; P R Reilly
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

4.  GINA, genetic discrimination, and genomic medicine.

Authors:  Robert C Green; Denise Lautenbach; Amy L McGuire
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

5.  Time to End the Use of Genetic Test Results in Life Insurance Underwriting.

Authors:  Mark A Rothstein
Journal:  J Law Med Ethics       Date:  2018-09       Impact factor: 1.718

6.  23andMe, the Food and Drug Administration, and the future of genetic testing.

Authors:  Patricia J Zettler; Jacob S Sherkow; Henry T Greely
Journal:  JAMA Intern Med       Date:  2014-04       Impact factor: 21.873

7.  Insurance Risk Classification in an Era of Genomics: Is a Rational Discrimination Policy Rational?

Authors:  Anya E R Prince
Journal:  Neb Law Rev       Date:  2017

Review 8.  Genetic discrimination and life insurance: a systematic review of the evidence.

Authors:  Yann Joly; Ida Ngueng Feze; Jacques Simard
Journal:  BMC Med       Date:  2013-01-31       Impact factor: 8.775

9.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.

Authors:  Amit V Khera; Mark Chaffin; Krishna G Aragam; Mary E Haas; Carolina Roselli; Seung Hoan Choi; Pradeep Natarajan; Eric S Lander; Steven A Lubitz; Patrick T Ellinor; Sekar Kathiresan
Journal:  Nat Genet       Date:  2018-08-13       Impact factor: 38.330

10.  Epigenetic Discrimination: Emerging Applications of Epigenetics Pointing to the Limitations of Policies Against Genetic Discrimination.

Authors:  Charles Dupras; Lingqiao Song; Katie M Saulnier; Yann Joly
Journal:  Front Genet       Date:  2018-06-08       Impact factor: 4.599

View more
  1 in total

1.  Employees' Views and Ethical, Legal, and Social Implications Assessment of Voluntary Workplace Genomic Testing.

Authors:  Kunal Sanghavi; W Gregory Feero; Debra J H Mathews; Anya E R Prince; Lori Lyn Price; Edison T Liu; Kyle B Brothers; J Scott Roberts; Charles Lee
Journal:  Front Genet       Date:  2021-03-17       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.